KR vs KZR · P/E 19, rev $147.64B vs $53.9M cap
Kroger Company (KR) versus Kezar Life Sciences Inc (KZR) — a side-by-side from cached financials, not a winner call.
Kroger Company (KR) is a grocery stores company listed on US.
Kezar Life Sciences Inc (KZR) is a biotechnology company listed on NASDAQ.
Latest reported KR revenue for 2026-01-31 was $147.64B. Net income was $1.02B. Revenue was up 0.4% from 2025-02-01 to 2026-01-31. KR currently screens at market cap $46.17B and trailing P/E 19.0.
Latest reported KZR revenue for 2024-12-31 was $0. Net income was -$83.7M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. KZR currently screens at market cap $53.9M.
KR currently screens at market cap $46.17B and trailing P/E 19.0. KZR currently screens at market cap $53.9M.
Not investment advice. Open the KR and KZR stock pages for the full models.
Not investment advice.